查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093289

介入放射學產品市場​​－2026-2032年全球市場預測

Interventional Radiology Products Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，介入放射學產品市場​​將成長至 198.8 億美元，複合年成長率為 6.61%。

主要市場統計數據
基準年 2025 127億美元
預計年份：2026年 135.3億美元
預測年份 2032 198.8億美元
複合年成長率 (%) 6.61%

介入性放射學產品：概述

介入放射學產品在全球向微創診斷和治療轉型中發揮核心作用，其實現的影像引導手術能夠減輕手術負擔、縮短恢復時間，並拓展腫瘤學、心臟病學、循環系統、胃腸病學、泌尿系統、婦科和周邊血管治療等領域的治療選擇。產品線包括血管造影術導管、導管導引線導管、支架、栓塞彈簧圈和栓塞顆粒、血栓切除裝置、活體組織切片針、切片穿刺針、下腔靜脈濾器、血管血栓除去裝置裝置、造影系統、造影劑注射裝置以及在透視、超音波、電腦斷層掃描 (CT) 和磁振造影(MRI) 下使用的各種附件。

介入放射學產品的變革性變化

介入放射學產品市場​​正因微創醫學、先進影像技術、數位化工作流程和多學科診療的整合而改變。過去主要透過開放性手術完成的手術，如今擴大採用影像引導下的導管、針頭和經皮介入方式進行。這種轉變在腫瘤栓塞和止血、血管疾病的血管成形術和支架置入術術、椎體增強術、影像引導下切片檢查、膿腫引流、腫瘤消融、透析通路維護、血管內中風治療和周邊血栓切除術等領域尤為明顯。

人工智慧對介入放射學的累積影響

人工智慧 (AI) 正在對整個介入放射學產品生態系統產生累積影響，涵蓋影像診斷、手術規劃、導航、工作流程自動化、品質保證和術後監測等各個方面。 AI 驅動的影像分析可以輔助臨床醫生進行血管分割、病灶檢測、腫瘤表徵、出血部位識別、血栓評估和器械路徑規劃。在複雜的介入手術中，機器學習工具正被擴大用於支援即時影像融合、自動解剖結構識別、輻射劑量最佳化和造影劑管理。

介入放射學在全球應用的關鍵區域性見解

在亞太地區，醫院基礎設施的擴建、癌症和心血管疾病發病率的上升、醫療技術投資的增加以及微創手術的普及，正在推動中國、印度、日本、韓國和澳洲等國介入放射學產品的使用。該地區情況各異，成熟的醫療體系已部署了先進的介入治療項目，而新興市場正在經歷快速的醫療能力建設。培訓、價格可負擔性、保險報銷的差異以及高階影像設備取得途徑的不均等因素，仍是推動介入放射學產品普及的關鍵因素。

介入性放射學產品關鍵群體分析

在東南亞國協，隨著醫療體系對影像設備、三級醫療設施和專科培訓的投資，介入放射學的普及程度正在逐漸提高。儘管新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國的基礎設施成熟度存在顯著差異，但慢性病負擔的加重和對微創手術需求的成長正在推動全部區域介入放射學的普及。採購決策通常需要在臨床能力、成本效益、服務支援以及訓練有素的操作人員數量之間取得平衡。

影響介入放射學產品需求的關鍵國家洞察

美國在手術方式多樣性、先進的介入手術室、不斷擴展的門診服務以及複雜血管內、腫瘤和介入神經放射學產品的引進方面主導，其採購決策受報銷方案、臨床證據、品質指標和監管合規性等因素驅動。加拿大在公共醫療保健體系、強大的學術醫療中心以及對公平醫療服務的重視方面具有優勢，但省級採購流程和產能限制影響了醫療設備的供應。在墨西哥，介入放射學服務正在主要城市的醫院中不斷發展，其需求受到私人醫療保健成長、心血管和腫瘤治療需求以及醫療服務取得不均等因素的影響。

為介入放射學行業的領導者提供的實用建議

產業領導者應優先考慮臨床差異化的介入放射學產品，這些產品應著重於提升手術效率、安全性、易操作性以及可衡量的患者療效。產品系列應與高需求適應症相匹配，包括栓塞術、腫瘤消融術、血管通路建立、周邊血管介入治療、神經血管介入治療、影像導引切片檢查、引流術和血栓切除術。應儘早透過註冊登記、真實世界資料收集、上市後監測以及在適當情況下進行對照臨床試驗來取得實證醫學證據。

深入了解介入性放射學產品的調查方法

本執行摘要基於系統的二手研究方法，參考了經核實的公共領域和行業相關資源，包括監管出版刊物、公共衛生統計數據、臨床實踐指南、同行評審的醫學文獻、醫院採購資訊來源、專業學會聲明以及微創影像引導治療領域的檢驗趨勢。分析重點在於對產品採納因素、臨床應用、技術發展、區域醫療基礎設施、監管因素以及不斷演變的手術流程進行定性研究途徑。

結論：微創醫學中的介入放射學產品

介入放射學產品正從單純的手術工具發展成為支持精準醫療、微創治療和以價值為導向的醫療服務的整合解決方案。最大的商機在於那些能夠改善導航、入路、栓塞控制、消融精度、血管通暢性、組織取樣、引流效率和手術安全性的產品。人工智慧、先進的影像技術和數位化工作流程工具透過改善治療計畫、提高治療一致性和追蹤治療結果，為產品提供了新的差異化優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 介入放射學產品市場​​：依產品類型分類

  • 消融裝置
    • 微波消融裝置
    • 射頻消融術裝置
  • 用於血管生成的球囊
  • 導管
  • 栓塞劑
    • 液態栓塞劑
    • 顆粒栓子
  • 栓塞線圈
  • 導管導引線
  • 血管閉合裝置
  • 血管支架
    • 頸動脈支架
    • 周邊血管支架

第8章 介入放射學產品市場​​：依應用領域分類

  • 介入神經放射學
    • 動脈瘤栓塞術
    • 中風血栓切除術
  • 腫瘤干預
    • 經動脈化療栓塞術
    • 腫瘤消融
      • 冷凍消融術
      • 微波消融裝置
      • 射頻消融術裝置
  • 疼痛管理
  • 血管介入

第9章 介入放射學產品市場​​：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第10章 介入放射學產品市場​​：依分銷管道分類

  • 直銷
  • 分銷商銷售額

第11章 介入性放射學產品市場​​：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 介入性放射學產品市場​​：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 介入放射學產品市場​​：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • AngioDynamics Inc
  • Asahi Intecc Co Ltd
  • B Braun SE
  • Becton Dickinson and Company
  • BIOTRONIK SE and Co KG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health Inc
  • Carestream Health Inc
  • Cook Group Inc
  • Edwards Lifesciences Corporation
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc
  • Guerbet SA
  • Hitachi Ltd
  • Hologic Inc
  • Koninklijke Philips NV
  • Medtronic plc
  • Merit Medical Systems Inc
  • Olympus Corporation
  • Penumbra Inc
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Sumitomo Bakelite Co Ltd
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-46132FF7A845

The Interventional Radiology Products Market is projected to grow by USD 19.88 billion at a CAGR of 6.61% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.70 billion
Estimated Year [2026] USD 13.53 billion
Forecast Year [2032] USD 19.88 billion
CAGR (%) 6.61%

Interventional Radiology Products: Executive Overview

Interventional radiology products are central to the global shift toward minimally invasive diagnosis and therapy, enabling image-guided procedures that reduce surgical trauma, shorten recovery times, and expand treatment options across oncology, cardiology, neurology, gastroenterology, urology, gynecology, and peripheral vascular care. The product landscape includes angiography catheters, guidewires, balloon catheters, stents, embolization coils and particles, thrombectomy devices, biopsy needles, drainage catheters, vena cava filters, vascular closure devices, ablation systems, contrast delivery devices, and accessories used across fluoroscopy, ultrasound, computed tomography, and magnetic resonance imaging guidance.

Demand is supported by well-documented clinical pressures, including the rising burden of cancer, cardiovascular disease, stroke, chronic kidney disease, liver disease, and age-associated vascular disorders. Health systems are prioritizing procedures that improve throughput, reduce inpatient stays, and support value-based care. Interventional radiology products also benefit from broader adoption of outpatient and ambulatory procedural models, improved imaging infrastructure, and increasing physician familiarity with endovascular and percutaneous techniques. At the same time, product selection is being shaped by safety, radiation reduction, device trackability, sterility assurance, reimbursement alignment, training availability, and regulatory compliance. As hospitals and specialty centers modernize procedural suites, the competitive focus is moving from standalone devices toward integrated procedural ecosystems that improve precision, workflow efficiency, and patient outcomes.

Transformative Shifts in Interventional Radiology Products

The interventional radiology products landscape is being reshaped by the convergence of minimally invasive medicine, advanced imaging, digital workflow, and multidisciplinary care. Procedures once dominated by open surgery are increasingly being performed through image-guided catheter-based, needle-based, and percutaneous approaches. This shift is particularly visible in embolization for tumors and bleeding control, angioplasty and stenting for vascular disease, vertebral augmentation, image-guided biopsies, abscess drainage, tumor ablation, dialysis access maintenance, and endovascular stroke or peripheral thrombectomy.

Hospitals are investing in hybrid operating rooms, advanced angiography suites, cone-beam CT, fusion imaging, dose-monitoring tools, and procedure-planning software to enhance clinical accuracy. Product design is also evolving toward lower-profile delivery systems, improved torque response, hydrophilic coatings, shape-memory materials, detachable embolic technologies, drug-coated platforms, and devices compatible with complex anatomies. In parallel, infection prevention and single-use device strategies are influencing procurement, particularly in high-volume interventional suites.

A major transformative shift is the movement from procedure volume optimization to outcome-driven product evaluation. Procurement teams increasingly assess devices based on procedural success, complication reduction, radiation exposure, length of stay, readmission risk, and total cost of care. Regulatory scrutiny over device safety, post-market surveillance, material biocompatibility, and clinical evidence is increasing across major jurisdictions. Training is another decisive factor, as the complexity of neurovascular, oncologic, and peripheral interventions requires structured education and simulation-based skill development. These shifts collectively favor interventional radiology products that combine clinical reliability, procedural efficiency, and measurable patient benefit.

Cumulative Impact of Artificial Intelligence on Interventional Radiology

Artificial intelligence is becoming a cumulative force across the interventional radiology product ecosystem, influencing imaging interpretation, procedural planning, navigation, workflow automation, quality assurance, and post-procedure monitoring. AI-enabled image analysis can assist clinicians in vessel segmentation, lesion detection, tumor characterization, bleeding localization, thrombus assessment, and device-path planning. In complex interventions, machine learning tools are increasingly being explored to support real-time image fusion, automatic anatomy recognition, radiation dose optimization, and contrast management.

The impact of AI extends beyond the procedure room. Scheduling algorithms can help optimize interventional suite utilization, while natural language processing may improve reporting consistency and capture structured procedural outcomes. Predictive analytics can support risk stratification for complications such as bleeding, access-site issues, restenosis, embolization response, or renal injury related to contrast exposure. When connected to hospital information systems and imaging archives, AI tools can improve longitudinal tracking of device performance and clinical outcomes.

For manufacturers and healthcare providers, the key opportunity lies in integrating AI with interventional radiology products without disrupting physician control or clinical accountability. Evidence generation, algorithm validation across diverse populations, cybersecurity, interoperability, and regulatory transparency remain essential. AI is not replacing interventional radiologists; it is augmenting decision-making, enabling more consistent execution, and supporting product ecosystems that are safer, more precise, and more data-driven. As adoption matures, AI-enabled interventional radiology will increasingly differentiate products based on usability, clinical evidence, integration with imaging platforms, and measurable contribution to procedural quality.

Key Regional Insights Across Global Interventional Radiology Adoption

In Asia-Pacific, interventional radiology products are supported by expanding hospital infrastructure, rising prevalence of cancer and cardiovascular disease, growing medical technology investment, and increased adoption of minimally invasive procedures in China, India, Japan, South Korea, and Australia. The region is diverse, with advanced interventional programs in mature health systems and rapid capacity building in emerging markets. Training, affordability, reimbursement variability, and uneven access to high-end imaging remain key factors shaping adoption.

North America remains one of the most clinically advanced regions for interventional radiology products, driven by strong use of image-guided procedures, established reimbursement pathways for many endovascular and percutaneous interventions, sophisticated hospital networks, and high availability of specialists. The United States and Canada emphasize outcome documentation, product safety, radiation management, and integration with digital health records, making clinical evidence and regulatory compliance central to purchasing decisions.

Latin America is advancing through improved access to tertiary care centers, growing awareness of minimally invasive alternatives, and increasing use of embolization, biopsy, drainage, angioplasty, and oncologic interventions. Brazil and Mexico are important procedural hubs, although procurement constraints, reimbursement inconsistency, and disparities between private and public healthcare systems influence product availability.

Europe demonstrates broad adoption of interventional radiology products through strong clinical guidelines, national health systems, specialist training pathways, and attention to patient safety and device regulation. Western European countries show mature use of vascular, oncologic, and neurointerventional technologies, while parts of Eastern Europe are expanding access through modernization of imaging infrastructure and specialist education.

The Middle East is investing in advanced hospital systems, specialist centers, and complex interventional capabilities, particularly across high-income Gulf countries. Demand is linked to noncommunicable disease burden, medical tourism initiatives, and government-led healthcare modernization. Africa shows growing need for interventional radiology products, especially for trauma, oncology, maternal health complications, vascular access, and infection-related drainage procedures; however, adoption is constrained by imaging availability, trained workforce shortages, financing limitations, and supply chain reliability.

Key Group Insights for Interventional Radiology Products

ASEAN countries are gradually expanding interventional radiology access as healthcare systems invest in imaging equipment, tertiary hospitals, and specialist training. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines differ significantly in infrastructure maturity, but regional adoption is supported by rising chronic disease burden and demand for less invasive procedures. Procurement decisions often balance clinical capability with affordability, service support, and availability of trained operators.

The GCC is positioned as a high-investment healthcare group, with interventional radiology products benefiting from hospital modernization, advanced diagnostic imaging, and government strategies to reduce outbound medical travel. Demand is reinforced by cardiovascular disease, diabetes-related vascular complications, cancer care needs, and growing use of specialist centers. Product adoption is closely linked to regulatory approvals, clinician training, and integration into premium hospital networks.

The European Union emphasizes harmonized medical device regulation, clinical evidence, traceability, post-market surveillance, and patient safety. This environment favors interventional radiology products with strong documentation, proven biocompatibility, clear labeling, and demonstrated procedural performance. Cross-border clinical collaboration and guideline-driven care support adoption of advanced embolization, ablation, vascular access, and endovascular technologies.

BRICS economies represent a combination of large patient populations, rising healthcare expenditure, and varied domestic manufacturing capabilities. Brazil, Russia, India, China, and South Africa are expanding interventional radiology capacity at different speeds, with major urban centers leading adoption. Affordability, local regulatory pathways, public procurement policies, and workforce development strongly influence product penetration.

The G7 reflects mature healthcare systems with high expectations for evidence-based device use, quality management, radiation safety, and procedural efficiency. Interventional radiology products in these countries are evaluated not only for technical performance but also for their contribution to clinical outcomes, hospital workflow, and long-term cost containment. NATO member countries overlap with several advanced healthcare markets and often emphasize trauma readiness, vascular intervention capability, defense medicine applications, and resilient medical supply chains, all of which support demand for reliable image-guided intervention products.

Key Country Insights Shaping Interventional Radiology Product Demand

The United States leads in procedural diversity, advanced interventional suites, outpatient expansion, and adoption of complex endovascular, oncologic, and neurointerventional products, with purchasing shaped by reimbursement, clinical evidence, quality metrics, and regulatory compliance. Canada benefits from publicly funded healthcare systems, strong academic centers, and emphasis on equitable access, though provincial procurement processes and capacity constraints influence device availability. Mexico is expanding interventional radiology services in major urban hospitals, with demand shaped by private healthcare growth, cardiovascular disease, oncology needs, and access disparities.

Brazil is a key Latin American center for image-guided interventions, supported by specialist expertise in large cities and demand for vascular and oncologic procedures, while public-private differences affect product access. The United Kingdom has established interventional radiology within national care pathways, emphasizing service standards, workforce planning, and minimally invasive alternatives that reduce hospital burden. Germany combines advanced hospital infrastructure, engineering-oriented clinical adoption, and strong use of vascular and oncologic interventions, while France maintains high standards in image-guided therapy, oncology-related procedures, and public healthcare integration. Russia has interventional radiology capabilities concentrated in major centers, with local procurement policies, supply considerations, and regional healthcare disparities influencing access. Italy and Spain demonstrate solid adoption of vascular, embolization, ablation, biopsy, and drainage products, supported by specialist practice and public hospital networks.

China is rapidly strengthening interventional radiology capacity through hospital expansion, domestic medical device development, and growing demand for cancer, stroke, and vascular disease treatment. India shows significant need for affordable interventional radiology products, driven by cardiovascular disease, oncology, trauma, and dialysis access, with adoption led by metropolitan hospitals and expanding tier-two city infrastructure. Japan has a mature interventional environment with strong emphasis on precision, quality, and aging-population needs, particularly in vascular, hepatobiliary, and oncologic procedures. Australia benefits from advanced imaging infrastructure, specialist training, and broad use of minimally invasive interventions across public and private hospitals. South Korea demonstrates strong adoption of advanced imaging, high procedural sophistication, and active use of interventional techniques in oncology, vascular disease, and hepatobiliary care.

Actionable Recommendations for Interventional Radiology Industry Leaders

Industry leaders should prioritize clinically differentiated interventional radiology products that address procedure efficiency, safety, deliverability, and measurable patient outcomes. Product portfolios need to align with high-demand applications such as embolization, tumor ablation, vascular access, peripheral intervention, neurovascular intervention, image-guided biopsy, drainage, and thrombectomy. Evidence generation should be embedded early through registries, real-world data capture, post-market surveillance, and comparative clinical studies where appropriate.

Manufacturers and distributors should strengthen physician education through simulation-based training, proctoring, digital learning platforms, and multidisciplinary case support. Regional strategies must reflect local reimbursement systems, regulatory requirements, procurement models, infrastructure readiness, and clinician skill levels. In emerging markets, affordability, service reliability, distributor quality, and training partnerships are essential. In mature markets, differentiation should focus on integrated workflow, reduced radiation exposure, lower complication risk, device compatibility, and documented performance.

AI and digital integration should be pursued carefully, with emphasis on interoperability, cybersecurity, transparent validation, and user-centered design. Organizations should also prepare for stricter sustainability and supply chain expectations, including packaging efficiency, sterilization practices, resilience of critical components, and compliance with evolving medical device regulations. Industry leaders that combine clinical evidence, procedural training, digital enablement, and region-specific access models will be best positioned to support the next phase of minimally invasive care.

Research Methodology for Interventional Radiology Product Insights

This executive summary is developed using a structured secondary research approach based on verified public-domain and industry-relevant sources, including regulatory agency publications, public health statistics, clinical practice guidelines, peer-reviewed medical literature, hospital procurement considerations, professional society statements, and documented trends in minimally invasive image-guided care. The analysis emphasizes qualitative assessment of product adoption drivers, clinical applications, technology shifts, regional healthcare infrastructure, regulatory factors, and evolving procedural workflows.

The methodology excludes market sizing, market estimation, market share calculation, and forecasting. Insights are synthesized through triangulation of clinical evidence, healthcare system indicators, disease-burden trends, technology adoption patterns, and regulatory developments. Regional, group, and country perspectives are interpreted through healthcare infrastructure maturity, access to imaging modalities, interventional radiology workforce availability, reimbursement environment, and demand for minimally invasive procedures. Emphasis is placed on data-backed directional insights and practical implications for product strategy, clinical adoption, and healthcare delivery.

Conclusion: Interventional Radiology Products in Minimally Invasive Care

Interventional radiology products are advancing from procedural tools into integrated solutions that support precision medicine, minimally invasive therapy, and value-based healthcare delivery. The strongest opportunities are linked to products that improve navigation, access, embolization control, ablation accuracy, vascular patency, tissue sampling, drainage efficiency, and procedural safety. Artificial intelligence, advanced imaging, and digital workflow tools are adding new layers of differentiation by improving planning, consistency, and outcome tracking.

Regional adoption will continue to depend on imaging infrastructure, trained specialists, reimbursement systems, regulatory readiness, and hospital investment priorities. Mature healthcare systems are likely to emphasize evidence, safety, and workflow integration, while emerging markets will prioritize access, affordability, training, and service support. Across all settings, the central requirement is clear: interventional radiology products must demonstrate clinical reliability, usability, and alignment with real-world healthcare needs. Stakeholders that invest in evidence-based innovation, clinician education, responsible AI integration, and resilient supply strategies will be well positioned to support the expanding role of image-guided minimally invasive care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Interventional Radiology Products Market, by Product Type

  • 7.1. Introduction
  • 7.2. Ablation Devices
    • 7.2.1. Microwave Ablation Devices
    • 7.2.2. Radiofrequency Ablation Devices
  • 7.3. Angioplasty Balloons
  • 7.4. Catheters
  • 7.5. Embolic Agents
    • 7.5.1. Liquid Embolics
    • 7.5.2. Particulate Embolics
  • 7.6. Embolization Coils
  • 7.7. Guidewires
  • 7.8. Vascular Closure Devices
  • 7.9. Vascular Stents
    • 7.9.1. Carotid Stents
    • 7.9.2. Peripheral Vascular Stents

8. Interventional Radiology Products Market, by Application

  • 8.1. Introduction
  • 8.2. Neuro Intervention
    • 8.2.1. Aneurysm Embolization
    • 8.2.2. Stroke Thrombectomy
  • 8.3. Oncology Intervention
    • 8.3.1. Transarterial Chemoembolization
    • 8.3.2. Tumor Ablation
      • 8.3.2.1. Cryoablation
      • 8.3.2.2. Microwave Ablation Devices
      • 8.3.2.3. Radiofrequency Ablation Devices
  • 8.4. Pain Management
  • 8.5. Vascular Intervention

9. Interventional Radiology Products Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Clinics
  • 9.4. Hospitals

10. Interventional Radiology Products Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Direct Sales
  • 10.3. Distributor Sales

11. Interventional Radiology Products Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Interventional Radiology Products Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Interventional Radiology Products Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. AngioDynamics Inc
  • 15.3. Asahi Intecc Co Ltd
  • 15.4. B Braun SE
  • 15.5. Becton Dickinson and Company
  • 15.6. BIOTRONIK SE and Co KG
  • 15.7. Boston Scientific Corporation
  • 15.8. Canon Medical Systems Corporation
  • 15.9. Cardinal Health Inc
  • 15.10. Carestream Health Inc
  • 15.11. Cook Group Inc
  • 15.12. Edwards Lifesciences Corporation
  • 15.13. Esaote SpA
  • 15.14. Fujifilm Holdings Corporation
  • 15.15. GE HealthCare Technologies Inc
  • 15.16. Guerbet SA
  • 15.17. Hitachi Ltd
  • 15.18. Hologic Inc
  • 15.19. Koninklijke Philips NV
  • 15.20. Medtronic plc
  • 15.21. Merit Medical Systems Inc
  • 15.22. Olympus Corporation
  • 15.23. Penumbra Inc
  • 15.24. Shimadzu Corporation
  • 15.25. Siemens Healthineers AG
  • 15.26. Stryker Corporation
  • 15.27. Sumitomo Bakelite Co Ltd
  • 15.28. Teleflex Incorporated
  • 15.29. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ABLATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABLATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MICROWAVE ABLATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MICROWAVE ABLATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROWAVE ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EMBOLIC AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIQUID EMBOLICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PARTICULATE EMBOLICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EMBOLIZATION COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GUIDEWIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GUIDEWIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VASCULAR STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAROTID STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAROTID STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAROTID STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEURO INTERVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEURO INTERVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEURO INTERVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANEURYSM EMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANEURYSM EMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANEURYSM EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STROKE THROMBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STROKE THROMBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STROKE THROMBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ONCOLOGY INTERVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ONCOLOGY INTERVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ONCOLOGY INTERVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TUMOR ABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CRYOABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CRYOABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CRYOABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MICROWAVE ABLATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROWAVE ABLATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MICROWAVE ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VASCULAR INTERVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VASCULAR INTERVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VASCULAR INTERVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DISTRIBUTOR SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DISTRIBUTOR SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DISTRIBUTOR SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 185. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 216. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 218. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 224. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 228. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 229. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 252. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 263. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. MEXICO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 296. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. GERMANY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
  • TABLE 318. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 319. RUSSIA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT